Skip to content

Portable Six-Lead Heart Monitor

This is your heart × 6.

Introducing KardiaMobile 6L.

The only FDA-cleared personal 6-lead EKG.

KardiaMobile 6L device

Take a 6-lead EKG outside of the doctor’s office anytime, anywhere.

6 times the data.

From the comfort of home.

Never before has more heart health information been available at your fingertips. Share detailed 6-lead EKGs with your doctor for a better view of your heart. And help your doctor provide you with even better care.

Two sensors on top.

And now, a third on the bottom.

KardiaMobile 6L has two electrodes on the top for your fingers, and one on the bottom to contact the skin of your left leg. KardiaMobile 6L delivers EKG leads I, II, III, aVL, aVR, and aVF. All without messy gels and wires.

6 is better than 1.


Kardia Mobile paired with an iPhone taking an EKG
  • 1-lead EKG
  • Detects AFib, Bradycardia, Tachycardia & Normal heart rhythm
  • 1-lead EKG gives your doctor reliable heart health information

KardiaMobile 6L

Kardia Mobile 6L paired with an iPhone taking a 6-lead EKG
  • 1-lead EKG / 6-lead EKG
  • Detects AFib, Bradycardia, Tachycardia & Normal heart rhythm
  • 6-lead EKG gives your doctor more detailed heart information
  • Provides doctors visibility into certain arrhythmias that are leading indicators of cardiovascular disease
  • KardiaMobile 6L is only available with a KardiaCare membership.

Tech Specs

EKG Characteristics

  • Six Lead ECG
  • 10 mV peak-to-peak input dynamic range
  • 30 second to 5 minute recording duration
  • 300 samples per second sampling rate
  • 14 bit resolution


  • 9.0 cm x 3.0 cm x 0.72 cm
  • Three 3 cm x 3 cm stainless steel electrodes


  • 24 grams


  • Bluetooth Low Energy technology
  • 1m wireless range


  • 3V CR2016 coin cell battery (included)
  • 200 hours operational time
  • 12 months typical use
thumbnail of Dr. Topol
“I am impressed with the quality and simplicity of 6-lead smartphone ECG tracings which will unquestionably sharpen our ability to diagnose heart rhythm and conduction abnormalities.”

Eric Topol, MD, Cardiologist

Founder and Director Scripps Research Translational Institute,

and author of the new book “Deep Medicine“

Dr. Topol has no financial relationship with or research support from AliveCor.

Please visit for a complete listing of indications, warnings and precautions.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our cookie policy ×